The Immune Assessment of PD-1 Antibody Therapy in Tumor
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Recruiting · NCT06693440 · Registry updated 2024-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Immune Assessment of PD-1 Antibody Therapy in Tumor | Adverse Event; Efficacy, Team | Recruiting | Not stated | 2024-11-18 | NCT06693440 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quanli Gao | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital | Zhengzhou | China | 2 |